CORC

在结果中检索

CORC

浏览/检索结果: 共128条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
One-Step Valorization of Calcium Lignosulfonate To Produce Phenolics with the Addition of Solid Base Oxides in the Hydrothermal Reaction System 期刊论文
ENERGY & FUELS, 2019, 卷号: 33, 期号: 5, 页码: 4302-4309
作者:  Han, Hongjing;  Li, Jinxin;  Wang, Haiying;  Han, Yejun;  Chen, Yanguang
收藏  |  浏览/下载：53/0  |  提交时间：2019/09/03
Development and validation of a predictive model for the diagnosis of solid solitary pulmonary nodules using data mining methods 期刊论文
JOURNAL OF THORACIC DISEASE, 2019, 卷号: 11, 期号: 3
作者:  Xiang, Yangwei;  Sun, Yifeng;  Liu, Yuan;  Han, Baohui;  Chen, Qunhui
收藏  |  浏览/下载：24/0  |  提交时间：2019/12/05
The REACH Trial: A Randomized Controlled Trial Assessing the Safety and Effectiveness of the Spiration (R) Valve System in the Treatment of Severe Emphysema 期刊论文
RESPIRATION, 2019, 卷号: 97, 期号: 5
作者:  Li, Shiyue;  Wang, Guangfa;  Wang, Changhui;  Gao, Xinglin;  Jin, Faguang
收藏  |  浏览/下载：31/0  |  提交时间：2019/12/05
Erlotinib versus gemcitabine/cisplatin in Chinese patients with EGFR mutation-positive advanced non-small-cell lung cancer: Crossover extension and post-hoc analysis of the ENSURE study 期刊论文
LUNG CANCER, 2019, 卷号: 130
作者:  Wu, Yi-Long;  Zhou, Caicun;  Lu, Shun;  Qin, Shukui;  Pan, Hongming
收藏  |  浏览/下载：22/0  |  提交时间：2019/12/05
Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303. 期刊论文
Thoracic cancer, 2019, 卷号: 10, 页码: 551-556
作者:  Si Xiaoyan;  Zhang Li;  Wang Hanping;  Zhang Xiaotong;  Wang Mengzhao
收藏  |  浏览/下载：34/0  |  提交时间：2019/11/19
Erlotinib versus gemcitabine/cisplatin in Chinese patients with EGFR mutation-positive advanced non-small-cell lung cancer: Crossover extension and post-hoc analysis of the ENSURE study 期刊论文
LUNG CANCER, 2019, 卷号: 130, 页码: 18-24
作者:  Wu, Yi-Long;  Zhou, Caicun;  Lu, Shun;  Qin, Shukui;  Pan, Hongming
收藏  |  浏览/下载：28/0  |  提交时间：2019/11/19
Integrated Transcriptome Analysis Reveals KLK5 and L1CAM Predict Response to Anlotinib in NSCLC at 3rd Line 期刊论文
FRONTIERS IN ONCOLOGY, 2019, 卷号: 9
作者:  Zhang, Bo;  Lu, Jun;  Shi, Qin;  Zhang, Lele;  Wu, Jun
收藏  |  浏览/下载：18/0  |  提交时间：2019/12/05
The impact of previous therapy strategy on the efficiency of anlotinib hydrochloride as a third-line treatment on patients with advanced non-small cell lung cancer (NSCLC): a subgroup analysis of ALTER0303 trial 期刊论文
TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 卷号: 8, 期号: 5, 页码: 575-+
作者:  Wang, Lili;  He, Zhen;  Yang, Sen;  Tang, Hong;  Wu, Yufeng
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/11
Erlotinib versus gemcitabine/cisplatin in Chinese patients with EGFR mutation-positive advanced non-small-cell lung cancer: Crossover extension and post-hoc analysis of the ENSURE study 期刊论文
Lung Cancer, 2019, 卷号: Vol.130, 页码: 18-24
作者:  Yi-Long Wu;  Caicun Zhou;  Shun Lu;  Shukui Qin;  Hongming Pan
收藏  |  浏览/下载：15/0  |  提交时间：2019/12/17
Asian  Chemotherapy  EGFR  Erlotinib  Non  small  cell  lung  cancer  
Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303 期刊论文
THORACIC CANCER, 2019, 卷号: 10, 期号: 3, 页码: 551-556
作者:  Si, Xiaoyan;  Zhang, Li;  Wang, Hanping;  Zhang, Xiaotong;  Wang, Mengzhao
收藏  |  浏览/下载：25/0  |  提交时间：2019/12/11

©版权所有 ©2017 CSpace - Powered by CSpace